SUMMARY Four strains of Corynebacterium diphtheriae were sent to UK participants in the UK National External Microbiological Quality Assessment Scheme, who were asked to examine the strains for toxin production by in vitro methods. Laboratories achieved 162/176 (92%) and 160/175 (91 %) correct results with two rapid toxin producers and 145/175 (82%) with a slow toxin producer. With a non-toxigenic strain 26/175 (15%) laboratories reported toxin production. Of the 173 laboratories reporting on all four strains, only 120 (69%) achieved the correct result for all. There was no significant association between the use of various methods and results, with the exception that laboratories using a full set of positive, weak positive, and negative controls made fewer errors than those not using controls. A number of unsatisfactory practices were revealed by the trial, however, and recommendations on preparation of inoculum, media, peptones, animal sera, and use of controls are made.
The United Kingdom National External Microbiological Quality Assessment Scheme has been described previously.' As part of the bacteriology portion of this scheme simulated specimens containing various pathogens are distributed to participants. Although most of these pathogens occur commonly in the UK, rarer but important pathogens are occasionally distributed for educational purposes. C diphtheriae has been distributed on a number of occasions with an average success rate in isolation and identification of 85%. No systematic information had been sought on toxigenicity testing of these strains, and in view of the continued occurrence of this species in the UK2 the Public Health Laboratory Service thought it would be useful to investigate the ability of laboratories to demonstrate toxin production in the event of another outbreak.
Material and methods

LABORATORIES PARTICIPATING
All 408 UK laboratories participating in the bacAccepted for publication 28 March 1984 teriology portion of the UK National Microbiological Quality Assessment Scheme were included in the trial. Most Table 1 shows the number of laboratories using various media for the toxigenicity test plate. Table 2 shows the number of laboratories using various peptones in the test media. Snell, Demello, Gardner, Kwantes, Brooks plate and thus obtain an early result. Several media not specifically designed for in vitro toxigenicity testing were used for the test plate. Unless evidence is available that these media work reliably, it is safer to use media specifically designed for the purpose. If other media are used it is essential to ascertain that they are suitable, either by assurance from the manufacturer that they have been tested for the purpose or preferably by testing in the user's laboratory. Although one manufacturer states in its catalogue that columbia agar may be used for toxigenicity testing, the medium is not specifically quality controlled for this property by the manufacturer.
ANTITOXINS
A wide variety of peptones were in use and it is known that peptones vary considerably in their suitability for Elek's test. 89 The use of Evans peptone (now unavailable) or Difco proteose peptone has been recommended.3 Although the catalogues of manufacturers of peptones should give an indication as to which peptones are suitable for toxigenicity tests, it is our experience that batch variation may occur. The onus is on the user to determine the suitability of each batch for the test system in use. Information on the animal sera used to supplement the test medium was not sought in this trial. Sera may vary considerably in their suitability for Elek's test. Traditionally, horse serum is used, but this is subject to batch variation. Newborn calf serum, usually readily available in virus laboratories and easily obtained from commercial sources, has been found to be eminently suitable at the Public Health Laboratory, Swansea, and batch variation has so far not been encountered. However, the suitability of each batch must be tested by the user.
It is disappointing that only 48% of laboratories were using adequate controls. It cannot be emphasised too strongly that controls are an essential part of any microbiological test, especially so with one as technically demanding as Elek's. The use of a rapid toxin producer, a slow toxin producer, and a nontoxigenic strain (all obtainable from the National Collection of Type Cultures, Central Public Health Laboratory, Colindale) as controls must be considered mandatory for this test. The "positive" controls confirm the ability of the system to detect the presence of toxin and, combined with the "negative" control, enable the toxin "line" to be identified.
A number of laboratories complained of difficulties in obtaining antitoxin. The Lister product is no longer available and there has been a supply problem in the past. Antitoxin is now readily available from the Swiss Serum and Vaccine Institute, Bern, and is imported by Regent Laboratories Ltd, Cunard Road, London NW10 6PN. Antitoxin is also stocked by some hospital pharmacies. Antitoxin normally needs to be diluted for use in in vitro toxigenicity tests and must be pretested to determine the correct concentration to be used. This normally is from 500 to 1000 units/ml.
As 
